0001144204-19-027766.txt : 20190522 0001144204-19-027766.hdr.sgml : 20190522 20190522171034 ACCESSION NUMBER: 0001144204-19-027766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090527 FILED AS OF DATE: 20190522 DATE AS OF CHANGE: 20190522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howell Stephen B. CENTRAL INDEX KEY: 0001464306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 19846703 MAIL ADDRESS: STREET 1: 2408 TIMBERLOCH PLACE, B-7 CITY: THE WOODLANDS STATE: TX ZIP: 77380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 BUSINESS PHONE: 2149055100 MAIL ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 4 1 tv522178_4.xml OWNERSHIP DOCUMENT X0306 4 2009-05-27 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001464306 Howell Stephen B. 1330 AVENUE OF THE AMERICAS 33RD FLOOR NEW YORK NY 10019 1 0 0 0 Common stock 2012-01-23 4 A 0 300 0 A 495 D Common stock 2015-05-11 4 A 0 75000 0 A 75495 D Stock Option (right to buy) 69 2009-05-27 4 A 0 500 0 A 2019-05-27 Common stock 500 500 D Stock Option (right to buy) 69 2009-05-27 4 A 0 200 0 A 2019-05-27 Common stock 200 200 D Stock Option (right to buy) 122.50 2010-05-26 4 A 0 600 0 A 2020-05-26 Common stock 600 600 D Stock Option (right to buy) 113.50 2011-05-26 4 A 0 700 0 A 2021-05-26 Common stock 700 700 D Stock Option (right to buy) 30.50 2012-05-24 4 A 0 700 0 A 2022-05-24 Common stock 700 700 D Stock Option (right to buy) 11.50 2012-12-11 4 A 0 2000 0 A 2022-12-11 Common stock 2000 2000 D Stock Option (right to buy) 18.50 2014-03-07 4 A 0 10000 0 A 2024-03-07 Common stock 10000 10000 D Stock Option (right to buy) 7.34 2015-05-11 4 A 0 75000 0 A 2025-05-11 Common stock 75000 75000 D Stock Option (right to buy) 2.31 2016-02-11 4 A 0 50000 0 A 2026-02-11 Common stock 50000 50000 D Stock Option (right to buy) 4.45 2016-12-13 4 A 0 50000 0 A 2026-12-13 Common stock 50000 50000 D Stock Option (right to buy) 16 2017-12-14 4 A 0 30000 0 A 2027-12-14 Common stock 30000 30000 D The share amount and price for this transaction have been adjusted to reflect a 50-for-1 reverse stock split on October 24, 2014. Vests 100% six months after grant date. /s/ Neena M. Patil, as Attorney-in-fact 2019-05-22